Literature DB >> 22268955

Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy.

Frank Pillekamp1, Moritz Haustein, Markus Khalil, Markus Emmelheinz, Rewa Nazzal, Roland Adelmann, Filomain Nguemo, Olga Rubenchyk, Kurt Pfannkuche, Matthias Matzkies, Michael Reppel, Wilhelm Bloch, Konrad Brockmeier, Juergen Hescheler.   

Abstract

Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) provide the unique opportunity to study the very early development of the human heart. The aim of this study was to investigate the effect of calcium and beta-adrenergic stimulation on the contractile properties of early hESC-CMs. Beating clusters containing hESC-CMs were co-cultured in vitro with noncontractile slices of neonatal murine ventricles. After 5-7 days, when beating clusters had integrated morphologically into the damaged tissue, isometric force measurements were performed during spontaneous beating as well as during electrical field stimulation. Spontaneous beating stopped when extracellular calcium ([Ca²⁺](ec)) was removed or after administration of the Ca²⁺ channel blocker nifedipine. During field stimulation at a constant rate, the developed force increased with incremental concentrations of [Ca²⁺](ec). During spontaneous beating, rising [Ca²⁺](ec) increased beating rate and developed force up to a [Ca²⁺](ec) of 2.5 mM. When [Ca²⁺](ec) was increased further, spontaneous beating rate decreased, whereas the developed force continued to increase. The beta-adrenergic agonist isoproterenol induced a dose-dependent increase of the frequency of spontaneous beating; however, it did not significantly change the developed force during spontaneous contractions or during electrical stimulation at a constant rate. Force developed by early hESC-CMs depends on [Ca²⁺](ec) and on the L-type Ca²⁺ channel. The lack of an inotropic reaction despite a pronounced chronotropic response after beta-adrenergic stimulation most likely indicates immaturity of the sarcoplasmic reticulum. For cell-replacement strategies, further maturation of cardiac cells has to be achieved either in vitro before or in vivo after transplantation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22268955     DOI: 10.1089/scd.2011.0312

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  35 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

2.  Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.

Authors:  Irene C Turnbull; Ioannis Karakikes; Gregory W Serrao; Peter Backeris; Jia-Jye Lee; Chaoqin Xie; Grant Senyei; Ronald E Gordon; Ronald A Li; Fadi G Akar; Roger J Hajjar; Jean-Sébastien Hulot; Kevin D Costa
Journal:  FASEB J       Date:  2013-10-30       Impact factor: 5.191

3.  Identification of cardiovascular lineage descendants at single-cell resolution.

Authors:  Guang Li; Karolina Plonowska; Rajarajan Kuppusamy; Anthony Sturzu; Sean M Wu
Journal:  Development       Date:  2015-01-29       Impact factor: 6.868

4.  A phenotypic in vitro model for the main determinants of human whole heart function.

Authors:  Maria Stancescu; Peter Molnar; Christopher W McAleer; William McLamb; Christopher J Long; Carlota Oleaga; Jean-Matthieu Prot; James J Hickman
Journal:  Biomaterials       Date:  2015-05-14       Impact factor: 12.479

Review 5.  Calcium signalling of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Sen Li; Gaopeng Chen; Ronald A Li
Journal:  J Physiol       Date:  2013-09-09       Impact factor: 5.182

6.  Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes.

Authors:  Sean P Sheehy; Anna Grosberg; Pu Qin; David J Behm; John P Ferrier; Mackenzie A Eagleson; Alexander P Nesmith; David Krull; James G Falls; Patrick H Campbell; Megan L McCain; Robert N Willette; Erding Hu; Kevin K Parker
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-26

Review 7.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

8.  Optical Method to Quantify Mechanical Contraction and Calcium Transients of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Katrina J Hansen; John T Favreau; Joshua R Gershlak; Michael A Laflamme; Dirk R Albrecht; Glenn R Gaudette
Journal:  Tissue Eng Part C Methods       Date:  2017-06-27       Impact factor: 3.056

9.  Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.

Authors:  Kevin S Bielawski; Andrea Leonard; Shiv Bhandari; Chuck E Murry; Nathan J Sniadecki
Journal:  Tissue Eng Part C Methods       Date:  2016-09-28       Impact factor: 3.056

Review 10.  Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Claire Robertson; David D Tran; Steven C George
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.